Dare Bioscience (DARE) EBITDA Margin (QoQ) (2017 - 2025)
Dare Bioscience (DARE) EBITDA Margin (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Dare Bioscience | 12.26 Mn | -360,284.49 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.22 Mn |
| Sep 30, 2025 | -18.04 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | -2.65 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | -6.45 Mn |
| Dec 31, 2023 | 55,359.00 |
| Jun 30, 2017 | -5,554.00 |
| Mar 31, 2017 | 546.00 |